22nd Century Group Finalizes $20M Highly Dilutive Offering Amid Going Concern Doubts
XXII is trading near its 52-week low of $3.38 (2.1% above the low) on light trading volume (0.1× avg).
Summary
22nd Century Group has finalized a $20 million registered direct offering of Series B Convertible Preferred Stock and warrants, which could result in over 5000% dilution to existing shareholders, as the company explicitly warns of substantial doubt regarding its ability to continue as a going concern.
Key Events · Financing and Capital Events · XXII
-
Finalized $20 Million Offering
The company finalized a registered direct offering of 20,000 shares of Series B Convertible Preferred Stock and warrants for a combined purchase price of $20.0 million.
-
Extreme Potential Dilution
The Series B Preferred Stock is convertible into 28,011,204 common shares (at a floor price of $0.714), and warrants allow purchase of an additional 5,602,244 shares, representing a potential increase of over 5000% to current outstanding shares.
-
Going Concern Warning
The company explicitly discloses "substantial doubt regarding our ability to continue as a going concern," highlighting severe financial distress.
-
Use of Proceeds
Net proceeds of approximately $19.0 million will be used to repurchase $9.65 million of Series A Convertible Preferred Stock and for general working capital.
Analysis · XXII · Manufacturing
This 424B5 filing finalizes the terms and pricing of the $20 million registered direct offering previously announced on March 20, 2026. The offering, structured with Series B Convertible Preferred Stock and accompanying warrants, is exceptionally dilutive, potentially increasing the outstanding common stock by over 5000% if all new securities are converted/exercised at their lowest possible prices. While the offering provides critical capital, with $9.65 million earmarked to repurchase existing Series A Preferred Stock and the remainder for working capital, it comes at a severe cost to existing equity holders. The company explicitly states "substantial doubt regarding our ability to continue as a going concern," underscoring the distressed nature of this capital raise. The pricing of the Series B conversion and warrants at $3.57 per share, while near the current market price, is still near the company's 52-week low, indicating a challenging fundraising environment. This transaction is a survival mechanism, but its highly dilutive terms fundamentally alter the investment thesis for current shareholders.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 40% of the 30 measured filings Wiseek scored 10 moved their stock by 5% or more by the next session's close. The median move was +0.45%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, XXII was trading at $3.45 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $1.8M. The 52-week trading range was $3.38 to $841.80. This filing was assessed with negative market sentiment and an importance score of 10 out of 10.